Name | N-Carbethoxy-4-piperidone |
---|---|
Synonyms |
Ethyl 4-oxo-1-piperidinecarboxylate
N-carboethoxy-4-piperidinone 1-CARBETHOXY-4-PIPERIDONE 4-oxo-piperidine-1-carboxylic acid ethyl ester EINECS 249-984-5 AURORA KA-3057 MFCD00006188 N-Ethoxycarbonyl-4-piperidinone 1-Ethoxycarbonyl-4-piperidinone ethyl 4-oxopiperidine-1-carboxylate N-ETHOXYCARBONYL-4-PIPERIDONE N-Carbethoxy-4-piperidone 1-Carbethoxy-4-piperidone,1-Ethoxycarbonyl-4-piperidone,Ethyl 4-oxo-1-piperidinecarboxylate 1-(Ethoxycarbonyl)-4-piperidone carbethoxy-4-piperidone 4-Oxo-1-piperidinecarboxylic acid ethyl ester N-Carbethoxy-4-piperidon Ethyl-4-oxopiperidin-1-carboxylat 1-carboethoxy-4-piperidone 1-Ethoxycarbonyl-4-oxopiperidine Loratadine impurity H N-CARBOETHOXY-4-PIPERIDONE 1-Piperidinecarboxylic acid, 4-oxo-, ethyl ester 1-Ethoxycarbonyl-4-piperidone N-Carbithoxy-4-Piperidone N-Carbethoxypiperidone Loratadine Impurity 8 |
Description | N-Carbethoxy-4-piperidone is a metabolite of Loratadine (HY-17043). Loratadine is a selective inverse peripheral histamine H1-receptor agonist, and shows anti-dengue-virus (DENV) activity[1][2][3]. |
---|---|
In Vitro | N-Carbethoxy-4-piperidone (piperidinone 4) shows toxicity to C. dubia, B. calyciflorus and P. subcapitata[1]. |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 273.4±33.0 °C at 760 mmHg |
Molecular Formula | C8H13NO3 |
Molecular Weight | 171.194 |
Flash Point | 87.8±0.0 °C |
Exact Mass | 171.089539 |
PSA | 46.61000 |
LogP | -0.31 |
Vapour Pressure | 0.0±0.6 mmHg at 25°C |
Index of Refraction | 1.483 |
Storage condition | 2-8°C |
Water Solubility | slightly soluble |
Hazard Codes | Xn:Harmful |
---|---|
Risk Phrases | R22;R36/38 |
Safety Phrases | S23-S24/25-S37/39-S26 |
WGK Germany | 3 |
HS Code | 2933399090 |
~98% 29976-53-2 |
Literature: SUVEN LIFE SCIENCES LIMITED; Nirogi, Ramakrishna; Mohammed, Abdul Rasheed; Yarlagadda, Suresh; Ravella, Srinivasa Rao; Shinde, Anil Karbhari; Kamphampati, Ramasastri; Roayapalley, Praveen Kumar; Jayarajan, Pradeep; Bhyrapuneni, Gopinadh; Patnala, Sriramachandra Murthy; Ravula, Jyothsna; Jasti, Venkateswarlu Patent: US2014/187581 A1, 2014 ; Location in patent: Paragraph 0195-0198 ; |
~% 29976-53-2 |
Literature: US2005/234046 A1, ; Page/Page column 59 ; US 20050234046 A1 |
~% 29976-53-2 |
Literature: Bioorganic and Medicinal Chemistry Letters, , vol. 18, # 20 p. 5439 - 5442 |
~% 29976-53-2 |
Literature: Tetrahedron Letters, , vol. 34, # 24 p. 3863 - 3866 |
~73% 29976-53-2 |
Literature: Praliev, K. D.; Belikova, N. A.; Isin, Zh. I.; Sokolov, D. V. Pharmaceutical Chemistry Journal, 1987 , vol. 21, # 1 p. 60 - 61 Khimiko-Farmatsevticheskii Zhurnal, 1987 , vol. 21, # 1 p. 70 - 71 |
~% 29976-53-2 |
Literature: Tetrahedron Letters, , vol. 34, # 24 p. 3863 - 3866 |
Precursor 7 | |
---|---|
DownStream 10 | |
HS Code | 2933399090 |
---|---|
Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |